Co-Authors
This is a "connection" page, showing publications co-authored by Claudio Mastroianni and Giancarlo Ceccarelli.
Connection Strength
1.813
-
Oxygen Sparing Effect of Bacteriotherapy in COVID-19. Nutrients. 2021 Aug 23; 13(8).
Score: 0.241
-
Persistent Systemic Microbial Translocation and Intestinal Damage During Coronavirus Disease-19. Front Immunol. 2021; 12:708149.
Score: 0.239
-
Oral Bacteriotherapy in Patients With COVID-19: A Retrospective Cohort Study. Front Nutr. 2020; 7:613928.
Score: 0.231
-
Is previous influenza-like illness a potential Trojan horse for COVID-19? Crit Care. 2020 08 14; 24(1):503.
Score: 0.224
-
Probiotics and COVID-19. Lancet Gastroenterol Hepatol. 2020 08; 5(8):721-722.
Score: 0.224
-
Is teicoplanin a complementary treatment option for COVID-19? The question remains. Int J Antimicrob Agents. 2020 Aug; 56(2):106029.
Score: 0.221
-
Impact of the 2017 measles outbreak on the emergency care system of a large tertiary-care teaching hospital in Italy: a retrospective analysis. Eur J Public Health. 2019 10 01; 29(5):966-971.
Score: 0.211
-
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection. Chemotherapy. 2021; 66(1-2):24-32.
Score: 0.058
-
Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep. 2020 10 15; 10(1):17419.
Score: 0.057
-
Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease. J Glob Antimicrob Resist. 2020 12; 23:67-69.
Score: 0.056
-
Increased IL-17 and/or IFN-? producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS. 2019 03 15; 33(4):627-636.
Score: 0.051